[EN] BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS<br/>[FR] DÉRIVÉS D'ACIDE BIARYL-PROPIONIQUE ET LEUR UTILISATION EN TANT QUE PRODUITS PHARMACEUTIQUES
申请人:SANOFI SA
公开号:WO2014154726A1
公开(公告)日:2014-10-02
The present invention relates to compounds of the formula (I), wherein X, R, R1, R2, D, E1, E2, E3, E4, G1, G2, G3 and G4 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are useful for the treatment of diseases such as atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases, for example. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use and pharmaceutical compositions comprising them.
Bromodomain and extraterminal protein-targeted probe enables tumour visualisation <i>in vivo</i> using positron emission tomography
作者:Catherine G. Fitzgerald Dickmann、Alexander F. McDonald、Nhi Huynh、Angela Rigopoulos、Zhanqi Liu、Nancy Guo、Laura D. Osellame、Michael A. Gorman、Michael W. Parker、Hui K. Gan、Andrew M. Scott、Uwe Ackermann、Ingrid J. G. Burvenich、Jonathan M. White
DOI:10.1039/d2cc04813b
日期:——
A fluorine-18 labelled probe was developed to target bromodomain and extraterminal (BET) proteins for molecular imaging of cancer with positron emission tomography.